| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62bf2c8e3be7f282db6e658eb393bed1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 |
| filingDate |
2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_239d0b04ee4a622617c67585508b7a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16e4821fdbb080f47dd42cafaae1e5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ea7a59c2587aa4c7dfc66024e73675b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d580246625e416a137a78a99f95a582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e930626b28b22123d44e1b091a5398fc |
| publicationDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105792833-A |
| titleOfInvention |
Methylcyclodextrin-based compositions for treating and/or preventing diseases by increasing HDL cholesterol levels |
| abstract |
The present invention relates to the novel use of a pharmaceutical composition comprising at least one methylcyclodextrin having a molar substitution (MS) between 0.05 and 1.5, for the treatment and/or prevention of Diseases to treat and/or prevent. The invention also relates to its use for the treatment and/or prevention of atherosclerosis or complications associated with atherosclerosis, and/or diseases of the central nervous system. The pharmaceutical compositions of the present invention may also be used to stimulate a reduction in circulating fatty acid and triglyceride levels, and to reduce or prevent atherosclerotic plaque. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107982546-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113490691-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109715141-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112334494-A |
| priorityDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |